Product apis-gpcr-g-protein

Home > products > apis> gpcr-g-protein

Catalog	name	Description	price
R-R-2876	HAEGTFTSDVSSYLE CAS No.926018-57-7	HAEGTFTSDVSSYLE/CAS No.926018-57-7 is a polypeptide from patent CN 102920658 B. GLP-I analog contains the sequence.	price>
R-R-2877	PA-8 CAS No.878437-15-1	PA-8/CAS No.878437-15-1 is a potent, selective and orally active PACAP type I (PAC1) receptor antagonist. PA-8 inhibits the phosphorylation of CREB induced by PACAP in PAC1-, but not VPAC1- or VPAC2-receptor. PA-8 also inhibits PACAP-induced cAMP elevation with an IC50 of 2 nM.	price>
R-R-2878	PACAP (6-38), human, ovine, rat TFA	PACAP (6-38), human, ovine, rat TFA is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively.	price>
R-R-2879	PAC1R antagonist 1 CAS No.2305204-24-2	PAC1R antagonist 1 (compound 3d)/CAS No.2305204-24-2 is a potent and orally active antagonist of PAC1 receptor. PAC1R antagonist 1 can inhibit pituitary adenylate cyclase-activating polypeptide (PACAP)- and nerve injury-induced allodynia.	price>
R-R-2880	PACAP (1-27), human, ovine, rat TFA	PACAP (1-27), human, ovine, rat TFA (PACAP 1-27 TFA) is the N-terminal fragment of PACAP-38, and is a potent PACAP receptor antagonist with IC50s of 3 nM, 2 nM and 5 nM for rat PAC1, rat VPAC1 and human VPAC2, respectively.	price>
R-R-2881	PACAP (1-38), amide, Biotin-labeled	PACAP (1-38), amide, Biotin-labeled is a biological active peptide. (Biotin-labeled HY-P0221)	price>
R-R-2882	PA-9 CAS No.1436004-46-4	PA-9/CAS No.1436004-46-4 is a pituitary adenylate cyclase-activating polypeptide (PACAP) type I (PAC1) receptor antagonist. PA-9 dose dependently inhibits PACAP-induced cAMP elevation with an IC50 of 5.6 nM. PA-9 can be used for the research of neuropathic and/or inflammatory pain.	price>
R-C-1183	Loxiglumide CAS:107097-80-3	Loxiglumide is a potent,orally active,and selective CCK-A receptor antagonist which stimulates calorie intake and hunger feelings in humans.Loxiglumide inhibits pancreatic secretion of digestive enzymes,and also blocks CCK-induced gastric secretions and emptying.Intravenous administration of loxiglumide antagonized the CCK-induced reduction of gastric emptying in rats,acceleration of intestinal transport in mice,increase in ileal motility in rabbits, gallbladder contraction in guinea pigs and acceleration of gallbladder emptying in mice.	price>
R-R-2883	(Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat) CAS No.213779-11-4	(Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat)/CAS No.213779-11-4 is a peptide and can be used as a parathyroid hormone (PTH) receptor ligand.	price>
R-C-1184	BD1047.2HBr CAS 138356-21-5	BD-1047 hydrobromide,a selective functional antagonist of sigma receptors,has antipsychotic activity in animal models predictive of efficacy in schizophrenia.	price>

...

163